Approval · Notice of Compliance 13504 · 2012
DOXEPIN: Notice of Compliance 13504
Issued July 23, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13504
- Date
- July 23, 2012
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antidepressant and Anxiolytic
Products in this notice
Medicinal ingredients
- DOXEPIN HCL 10 MG per CAP
- DOXEPIN HCL 25 MG per CAP
- DOXEPIN HCL 50 MG per CAP
- DOXEPIN HCL 75 MG per CAP
- DOXEPIN HCL 100 MG per CAP
- DOXEPIN HCL 150 MG per CAP